Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |